Perfil
Racheli Ofir is currently the Co-Chief Executive and Chief Technology Officer at Betalin Therapeutics Ltd. Prior to this, she worked at Pluri, Inc. as the Vice President of Data and Intellectual Property from 2007 to 2022.
She holds a doctorate degree from both Technion-Israel Institute of Technology and Israel Institute of Technology.
Cargos activos de Racheli Ofir
| Empresas | Cargo | Inicio |
|---|---|---|
Betalin Therapeutics Ltd.
Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Develops micro-pancreas and cell technology | Director Ejecutivo | 01/12/2022 |
Antiguos cargos conocidos de Racheli Ofir.
| Empresas | Cargo | Fin |
|---|---|---|
| PLURI INC. | Director Técnico/Científico/I+D | 01/05/2022 |
Formación de Racheli Ofir.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Pluri, Inc.
Pluri, Inc. BiotechnologyHealth Technology Develops placenta-based cell therapy products for the treatment of muscle trauma and hematological disorders, radiation damage and inflammation | Health Technology |
Technion-Israel Institute of Technology
Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Israel Institute of Technology
Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Betalin Therapeutics Ltd.
Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Develops micro-pancreas and cell technology | Technology Services |
- Bolsa de valores
- Insiders
- Racheli Ofir
















